Congressional Update Audioconference Series, Food and Drug Law Institute

  • 10.4.2007 | -
  • Washington, DC

Partner Scott Lassman lead a discussion on F·D·A³: PDUFA Reauthorization and Post-Market Authority as part of the FDLI Congressional Update Audio-Conference Series: FDA Reauthorization Legislation.



Not sure where to start?

Let our Knowledge Navigator direct you to content specific to where you are on your journey.

Get Started!
Rss Feed
2.24.2025
Balatro and others re-rated by PEGI after successful appeal, prompting a rule revision 
2.24.2025
Anthropic’s Claude 3.7 Sonnet takes aim at OpenAI and DeepSeek in AI’s next big battle 
2.24.2025
Acid Labs raises $8M to build viral Web3 games on social chat platforms 
Featured
blog-launch-550x370

This blog post explores certain specific terms in term sheets that will create legally binding obligations.

Schall launch feature

Partner Gary Schall shares some practical advice about term sheets: Don’t attempt any transaction without one.

2.20.2025
Corporate Transparency Act: Judge Clears Way for CTA; Reporting Requirements Back in Effect
2.12.2025
Corporate Transparency Act: It’s Still Paused (For Now)
12.27.2024
Corporate Transparency Act: Preliminary Injunctive Relief Reinstated by Fifth Circuit (For Now)